View graph of relations
  1. 2019
  2. Published
  3. Published
  4. Published
  5. Published
  6. Published
  7. Published
  8. 2018
  9. Published
  10. Published
  11. Published
  12. Published
  13. Published
  14. Published
  15. Published
  16. Published
  17. 2017
  18. Published
  19. Published
  20. Published
  21. 2016
  22. Published
  23. Published
  24. Published
  25. Published
  26. Published
  27. Published
  28. 2015
  29. Published
  30. Published
    Adriaanse, M. P. M., van der Sande, L. J. T. M., van den Neucker, A. M., Menheere, P. P. C. A., Dompeling, E., Buurman, W. A., & Vreugdenhil, A. C. E. (2015). Evidence for a Cystic Fibrosis Enteropathy. PLOS ONE, 10(10), [e0138062]. https://doi.org/10.1371/journal.pone.0138062
  31. Published
  32. Published
  33. Published
  34. Published
  35. Published
  36. Published
    Gross, S., Adriaanse, M. P., Nijeboer, P., Tack, G. J., van Hoogstraten, I. M., Bouma, G., ... Bontkes, H. J. (2015). Serum intestinal-fatty acid binding protein as a biomarker for refractory celiac disease. Journal of Gastrointestinal and Liver Diseases, 24(2), 258-259.
  37. 2014
  38. Published
    Vreugdenhil, A. C. (2014). Hepatitis. In Werkboek KinderMDL Amsterdam: VU Boekhandel / UItgeverij BV.
  39. Published
    Adriaanse, M. P., Vreugdenhil, A. C., Groeneweg, M., Bruggenwirth, H. T., Castelijns, S. J., van der Ent, C. K., ... Tilanus, M. G. (2014). HLA frequencies and associations in cystic fibrosis. Tissue Antigens, 83(1), 27-31. https://doi.org/10.1111/tan.12265
  40. Published
  41. Published
    Vreugdenhil, A. (2014). Pancreasaandoeningen. In Werkboek KinderMDL VU Boekhandel / UItgeverij BV.
  42. Published
  43. 2013
  44. Published
    Tack, G. J., van de Water, J. M., Bruins, M. J., Kooy-Winkelaar, E. M., van Bergen, J., Bonnet, P., ... Koning, F. (2013). Consumption of gluten with gluten-degrading enzyme by celiac patients: A pilot-study. World Journal of Gastroenterology, 19(35), 5837-5847. https://doi.org/10.3748/wjg.v19.i35.5837
  45. Published
  46. Published
  47. 2012
  48. Published
  49. 2011
  50. Published
    Vreugdenhil, A. C. E., Wolters, V. M., Adriaanse, M. P., van den Neucker, A. M., van Bijnen, A. A., Houwen, R., & Buurman, W. A. (2011). Additional value of serum i-fabp levels for evaluating celiac disease activity in children. Scandinavian Journal of Gastroenterology, 46(12), 1435-1441. https://doi.org/10.3109/00365521.2011.627447
  51. Published
    De Bie, C. I., Hummel, T. Z., Kindermann, A., Kokke, F. T., Damen, G. M., Kneepkens, C. M., ... De Ridder, L. (2011). The duration of effect of infliximab maintenance treatment in paediatric Crohn's disease is limited. Alimentary Pharmacology & Therapeutics, 33(2), 243-250. https://doi.org/10.1111/j.1365-2036.2010.04507.x
  52. 2010
  53. Published
    Vreugdenhil, A. C. E., van Mil, E. G., & van Heurn, L. W. E. (2010). Een extreem dik kind: is operatieve behandeling wenselijk? In Praktische Pediatrie, Nr. 2
  54. 2009
  55. Published
  56. 2007
  57. Published
    De Backer, I. C., van Breda, E., Vreugdenhil, A. C. E., Nijziel, M. R., Kester, A. D. M., & Schep, G. (2007). High-intensity strength training improves quality of life in cancer survivors. Acta Oncologica, 46(8), 1143-1151. https://doi.org/10.1080/02841860701418838
  58. 2004
  59. Published
  60. 2003
  61. Published
  62. Published
  63. 2001
  64. Published
  65. 2000
  66. Published
Previous 1 2 Next